Medications

Repurposing FDA-approved drugs may help combat COVID-19

Several FDA-approved drugs—including for type 2 diabetes, hepatitis C and HIV—significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists ...

Diseases, Conditions, Syndromes

Malaria discovery could expedite antiviral treatment for COVID-19

The study, conducted by an international team and led by RMIT University's Professor Christian Doerig, outlines a strategy that could save years of drug discovery research and millions of dollars in drug development by repurposing ...

Medical research

Age-related hepatitis B infection and the gut microbiome

(Medical Xpress)—The hepatitis B virus (HBV), which affects the liver, behaves differently in different people depending on genetics and the age the person is when infected. Ninety-five percent of adults who contract hepatitis ...

Diseases, Conditions, Syndromes

How to cure more hepatitis C patients

There is a cure or the nation's deadliest infectious disease, hepatitis C, but at tens of thousands of dollars per patient in upfront costs, most insurance companies can't afford to provide the treatment to all of the estimated ...

Diseases, Conditions, Syndromes

Hepatitis C now leading infectious disease killer in U.S.

(HealthDay)—The number of hepatitis C-linked deaths in the United States reached a record high in 2014, and the virus now kills more Americans than any other infectious disease, health officials report.

Diabetes

NAFLD linked to unfavorable metabolic profile in T2DM

(HealthDay)—For obese patients with type 2 diabetes mellitus (T2DM), nonalcoholic fatty liver disease (NAFLD) is associated with an unfavorable metabolic profile, according to a study published online Feb. 9 in Diabetes ...

page 4 from 40